NCT02708173

Safety Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged 3 Years and Older

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Beijing Chaoyang District Centre for Disease Control and Prevention · Academic / Other
• Sex: All
• Age: 3 Years – 60 Years
• Healthy volunteers: Accepted

Summary

This study evaluates the safety of Quadrivalent Influenza Virus Vaccine in Healthy People Aged years 3 to 60.40 Subjects will be equally divided into 2 groups,including 3-17 years old and 18-60 years old.Adult group first receive one dose of Quadrivalent Influenza Virus Vaccine.Then minors group also receive one dose of Quadrivalent Influenza Virus Vaccine after 7 days.

Conditions

• Quadrivalent Influenza Virus Vaccine

Interventions

Type	Name	Description
BIOLOGICAL	One dose of Quadrivalent Influenza Virus Vaccine
BIOLOGICAL	One dose of Quadrivalent Influenza Virus Vaccine

Timeline

• Start date: 2016-03-01
• Primary completion: 2016-03-01
• Completion: 2016-06-01
• First posted: 2016-03-15
• Last updated: 2016-08-15

Locations

1 site across 1 country: China